Search company, investor...

Founded Year

2005

Stage

Acquired | Acquired

Total Raised

$29.9M

Valuation

$0000 

About Corventis

Corventis is a provider in wearable, wireless technologies for cardiac disease. The company's patient- and physician-friendly technology has helped patients around the world and is designed to enable reliable and timely detection of clinical events without impacting lifestyle.

Headquarters Location

2033 Gateway Place Suite 100

San Jose, California, 95110,

United States

408-790-9300

Loading...

Loading...

Corventis Patents

Corventis has filed 33 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/18/2014

9/10/2019

Cardiovascular physiology, Medical equipment, Health informatics, Cardiology, Beta blockers

Grant

Application Date

3/18/2014

Grant Date

9/10/2019

Title

Related Topics

Cardiovascular physiology, Medical equipment, Health informatics, Cardiology, Beta blockers

Status

Grant

Latest Corventis News

Mobile Cardiovascular Telemetry Systems Market Revenue, Recommendations, Estimations and Potential Targets|Medtronic plc., Koninklijke Philips N.V., Corventis Inc

Sep 4, 2020

|Medtronic plc., Koninklijke Philips N.V., Corventis Inc Pune, Maharashtra, India, September 4 2020 (Wiredrelease) MarketResearch.Biz –:The recent report posted via MarketResearch.Biz on Mobile Cardiovascular Telemetry Systems market offers critical market insights in conjunction with targeted segmentation evaluation . The report examines key using elements which might be anticipated to drive the increase of the market. Global Mobile Cardiovascular Telemetry Systems Market Research Report offers crucial data on numerous market situations, for example, ability improvement elements, elements controlling the advancement, market possibilities, and risks to the global market. Also, the report widely facilities round competitive evaluation of Mobile Cardiovascular Telemetry Systems Market. The competitive evaluation section includes key producers, recent players, providers, market strategies, ability chances, operation panorama, and evaluation of the traits of the Mobile Cardiovascular Telemetry Systems market. The market consequences are targeted by round the present market scenario. To gauge and expect the competitive scenario on this market. This report will likewise assist all of the producers and speculators to have an advanced comprehension of the investments to recognize wherein the market is heading. For Better Understanding, Request A Free Pdf Sample Copy Of Mobile Cardiovascular Telemetry Systems Market Here@ https://marketresearch.biz/report/mobile-cardiovascular-telemetry-systems-market/request-sample (***Our FREE SAMPLE COPY of the report offers a quick advent to the studies report outlook, TOC, a listing of tables and figures, an outlook to key players of the market, and comprising key regions.) Leading players of Mobile Cardiovascular Telemetry Systems including: Medtronic plc., Koninklijke Philips N.V., Corventis Inc, GE Helathcare, Medicalgorithmics SA, ScottCare Corporation, LifeWatch Services Inc, BioTelemetry Inc, Biotricity Inc, Medicomp Inc Segmentation by type: Single Channel, Multi-Channel. Segmentation by application: Hospitals, Homecare Settings Download Now And Browse Complete Information On The COVID 19 Impact Analysis On Mobile Cardiovascular Telemetry Systems Market: https://marketresearch.biz/report/mobile-cardiovascular-telemetry-systems-market/covid-19-impact Mobile Cardiovascular Telemetry Systems Report Covers Following Questions: 1. What will the market increase rate, increase momentum of Mobile Cardiovascular Telemetry Systems market 2. What is the envisioned size of the rising Mobile Cardiovascular Telemetry Systems market in 2029? 3. Which section is anticipated to account for the most important Mobile Cardiovascular Telemetry Systems market percentage by 2029? 4. What are sales, revenue, and value evaluation by areas of Mobile Cardiovascular Telemetry Systems market? 5. What are the market risk, market possibility and market review of the Mobile Cardiovascular Telemetry Systems market? 6. Who are the distributors, dealers, and buyers of Mobile Cardiovascular Telemetry Systems market? Moreover, the report in brief research the overall performance of each historic statistics in conjunction with the current traits. It consists of an entire evaluation of various attributes inclusive of production base, type, and size. This report evaluates the market segmentation in conjunction with the competitive panorama worldwide in addition to the local level. The report additionally discusses approximately the growing want for Mobile Cardiovascular Telemetry Systems market. Reasons for Buying this Report The worldwide Mobile Cardiovascular Telemetry Systems market report offers a forward-searching attitude on Driving and restraining elements of the market increase. Ten-year forecast assessed on the premise of how the market is expected to grow Future evaluation is moreover supplied on how the market is predicted to grow Past market dynamics of the past years Helps in know-how the important thing product segments and their future estimations Focused evaluation of converting competitive dynamics to recognize the procedures utilized by the numerous key players withinside the market Any Query? Feel Free To Enquire Here: https://marketresearch.biz/report/mobile-cardiovascular-telemetry-systems-market/#inquiry Report on Global Mobile Cardiovascular Telemetry Systems Market 2020 contains of 10 Sections in Table as follows: – Industry Overview of Mobile Cardiovascular Telemetry Systems: Includes numerous definitions, specs in conjunction with its features, and applicability. Mobile Cardiovascular Telemetry Systems Manufacturing Cost & Price Structure Analysis: Raw Material required and their suppliers, price shape evaluation on the subject of production, structural evaluation of promoting price, break-even factor evaluation, and procedure evaluation. Production Description: Capacity and Commercial Production Date of Mobile Cardiovascular Telemetry Systems Major Manufacturers in 2020, Manufacturing Plants Distribution, R&D Status, and Technology Source and Raw Materials Sources Analysis. Global Mobile Cardiovascular Telemetry Systems Overall Market Overview: Overall Market Analysis starting from Production to Revenue Global Mobile Cardiovascular Telemetry Systems segmentation: By Type: – Sales and Factors impacting the increase in sales. By Application: – Consumer evaluation in conjunction with the end-user evaluation. Analysis of Major Manufacturers of Mobile Cardiovascular Telemetry Systems across the world: Examination of every Company profiles, picture of the object and details, sales, preceding costs, income, Gross Margin Analysis, Business Region Distribution Analysis The trend of Mobile Cardiovascular Telemetry Systems Market: Mobile Cardiovascular Telemetry Systems Market Trend Analysis, Market Size (Volume and Value) Forecast, Regional Market Trend, Market Trend via way of means of Product Type and Applications. Browse The Complete TOC of the Report: https://marketresearch.biz/report/mobile-cardiovascular-telemetry-systems-market/#toc The Mobile Cardiovascular Telemetry Systems market report reads pin-direct evaluation for converting extreme dynamics in regards to converting factors that drive or limits market improvement. The report is comprehensively visualized to forecast the market factor of view and possibilities wherein it has an extension to expand in the future. Basically, the report segregates the potential of the market withinside the current and the upcoming opportunities from numerous edges in detail. About Us: MarketResearch.Biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. The company offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations across the globe, and deliver our offerings in the shortest possible turnaround time. Contact Us:

Corventis Frequently Asked Questions (FAQ)

  • When was Corventis founded?

    Corventis was founded in 2005.

  • Where is Corventis's headquarters?

    Corventis's headquarters is located at 2033 Gateway Place, San Jose.

  • What is Corventis's latest funding round?

    Corventis's latest funding round is Acquired.

  • How much did Corventis raise?

    Corventis raised a total of $29.9M.

  • Who are the investors of Corventis?

    Investors of Corventis include Medtronic, Kleiner Perkins Caufield & Byers, DAG Ventures and Mohr Davidow Ventures.

  • Who are Corventis's competitors?

    Competitors of Corventis include NeoChord, Propeller Health, CardioDx, LipoScience, West Health Investment Fund and 7 more.

Loading...

Compare Corventis to Competitors

h
hanse chemie GmbH

Hanse Chemie GmbH specializes in the development of specialty chemical additives and solutions within the domain of interfacial chemistry. The company offers a range of products that enhance the efficiency of industrial manufacturing processes and create unique products, focusing on effects such as defoaming, spreading, dispersing, and emulsifying. Hanse Chemie GmbH caters to various market segments, including agrochemicals, construction, plastics, packaging, e-mobility, and electronics. It is based in Redmond, Washington.

Atonomics Logo
Atonomics

Atonomics develops a point of care diagnostic device based on an electro-mechanical concept. This technology changes the way that DNA and antibodies are used in point of care diagnosis.

K
Kjaya

Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.

C
Corassist Cardiovascular

CorAssist operates as a clinical-stage medical device company. It develops therapeutic products for treating heart failure with preserved ejection fraction. It was founded in 2003 and is based in Haifa, Israel.

C
CathRx

CathRx is a medical device company focused on the development and manufacture of electrophysiology catheters for diagnosing and treating cardiac arrhythmias. The company's main offering is a range of catheters that incorporate proprietary technology to overcome limitations of conventional single-use catheter design, allowing for reprocessing and reuse, which helps hospitals reduce economic and environmental costs. CathRx primarily serves the healthcare industry, particularly hospitals and medical facilities. It is based in Australia.

M
MetaCure

MetaCure is a clinical-stage device company focused on the treatment of adult type II diabetes via an implantable pulse generator delivering electrical stimulation via gastric contractility modulation.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.